Thermo Fisher Scientific's $13.6 Billion Acquisition of Life Technologies Boosts Flagging M&A Numbers May 01, 2013 | Press Release
Burrill Securities Launches Institutional Breakthrough Series April 29, 2013 | Press Release
Big Biotech Outpaces Big Pharma, Burrill & Company says April 16, 2013 | Press ReleaseSee all News
For information on Biotech 2013-Life Sciences: Capturing Value and other Burrill & Company publications, click here.
Burrill Canadian Biotech Weekly News
The Burrill Canadian Biotech News is a premier weekly biotechnology publication, which has been reporting on the Canadian biotech industry for over 18 years. It is the publication of record for news, events and the capital markets in Canada’s growing biotech and life sciences sectors. Its continuing commitment to an outstanding level of excellence is fueled by founder and Editor-in-Chief, Peter Winter - a bioscientist and award-winning journalist with over 25 years experience of consulting, writing and editing. He is Canada's leading expert and commentator on Canadian biotechnology and his opinions, reports and commentaries are widely sought by government organizations and companies.
A one-year subscription to Canadian Biotech News is US$775.00. Published 46 times per year (double issues in August and December), each issue brings you the latest news and analysis on Canada’s rapidly evolving public and private companies and organizations. Your paid subscription comes with a free copy of Biotech 2009: Life Sciences: Navigating the Sea Change (a $450 value)
Click to view sample issues:
VOLUME 18 NUMBER 12
VOLUME 18 NUMBER 13
VOLUME 18 NUMBER 14
Click here to subscribe to the Canadian Biotech News.
Add to cart$775.00